↓ Skip to main content

Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics

Overview of attention for article published in Frontiers in Pharmacology, October 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
Published in
Frontiers in Pharmacology, October 2021
DOI 10.3389/fphar.2021.747194
Pubmed ID
Authors

Anna D. Louie, Kelsey Huntington, Lindsey Carlsen, Lanlan Zhou, Wafik S. El-Deiry

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 14%
Unspecified 5 11%
Student > Bachelor 4 9%
Researcher 4 9%
Student > Master 4 9%
Other 5 11%
Unknown 16 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 16%
Medicine and Dentistry 5 11%
Unspecified 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Nursing and Health Professions 1 2%
Other 6 14%
Unknown 17 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2022.
All research outputs
#16,123,626
of 25,837,817 outputs
Outputs from Frontiers in Pharmacology
#5,417
of 20,002 outputs
Outputs of similar age
#224,660
of 444,460 outputs
Outputs of similar age from Frontiers in Pharmacology
#305
of 1,126 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,460 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,126 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.